Related Experiment Videos
[Retinopathia praematurorum: risks and critical timing]
Insights
This study found that gestational age is the primary predictor for retinopathy of prematurity (ROP) risk in premature infants. Birth weight is most informative for determining the age of ROP stage III onset, aiding in screening timing.
Area of Science:
- Ophthalmology
- Neonatology
- Perinatal Medicine
Context:
- Retinopathy of prematurity (ROP) is a significant cause of visual impairment in premature infants.
- Accurate risk assessment and screening timing are crucial for effective ROP management.
Purpose:
- To characterize the risk factors associated with the incidence and onset of retinopathy of prematurity (ROP) in preterm infants.
- To develop predictive models for ROP risk and stage III onset based on gestational age, birth weight, and oxygen therapy duration.
Summary:
- The first study analyzed 487 preterms, finding gestational age to be the strongest predictor of acute ROP (R = 2(39-SSW).0.5).
- The second study identified birth weight as the most informative factor for the age of ROP stage III onset (LAT = 100-BW.34).
- These findings provide quantitative approximations to guide ROP screening protocols.
Impact:
- Provides clinicians with improved tools for estimating ROP risk and optimizing screening schedules for premature infants.
- Contributes to the early detection and timely intervention of ROP, potentially reducing long-term visual impairment.
- Enhances understanding of the interplay between prematurity parameters and ROP development.
Abstract:
Two prospective studies were performed to characterize the retinopathy of prematurity (ROP) risk in preterms further. In the first study the gradual relationship between birth weight, gestational age and duration of oxygen therapy and the incidence of ROP was evaluated. A total of 487 preterms were enrolled in this survey. Seventeen percent (67 babies) of 389 surviving children presented clinical signs of acute ROP. Among the analyzed risk factors "gestational" age provided the best correlation with the manifestation of acute ROP. According to the nonlinear regression model the risk of acute ROP can approximately be calculated as: R = 2(39-SSW).0.5 (R = relative risk of ROP in %). The second study focused on the relationship between individual risk factors and the age at stage III onset. The mean age of the first ROP stage III diagnosis was 66 days after birth at an average gestational age (post-menstrual age) of 37.0 weeks. Multifactorial analysis clearly demonstrated that birth weight was most informative among the tested set of parameters concerning the age at onset of ROP stage III. Best fitted linear regression of this relation was: LAT = 100-BW.34 (LAT = age at onset of ROP III expressed as postnatal days; BW birthweight measured in kg). It is suggested to take this approximation into account for the timing of ROP screening.